講演・口頭発表等 - 玉村　啓和

分割表示  645 件中 21 - 40 件目  ／  全件表示 >>

  1. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. Structure-Activity Relationship Studies Targeting a SARS-CoV-2 Papain-like Protease and their Application to an Mpox I7L Protease. MCCB Conference Darwin 2025 2025.04.16 Darwin, Australia

  2. Arioka M, Kobayakawa T, Tsuji K, Tamamura H. Development of a Synthetic Strategy for Fluoroalkene Dipeptide Isosteres as Peptidomimetics and their Application. MCCB Conference Darwin 2025 2025.04.14 Darwin, Australia

  3. Tsuji K, Huang X, Kobayakawa T, Burke TR Jr., Tamamura H. DEVELOPMENT OF BINDING ASSAYS FOR THE EVALUATION OF POLO-LIKE KINASE 1 INHIBITORS WITH WIDE RANGE AFFINITIES. 10th Indian Peptide Symposium 2025.02.28 Pune, India

  4. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. DEVELOPMENT OF NOVEL SARS-COV-3 PAPAIN-LIKE PROTEASE INHIBITORS AND THEIR POTENTIAL APPLICATION TO ANTI-MPOX AGENTS. 10th Indian Peptide Symposium 2025.02.28 Pune, India

  5. Yamamoto K, Kobayakawa T, Tsuji K, Tamamura H. CHLOROALKENE-TYPE DIPEPTIDE ISOSTERES APPLICATED FOR AMYLOID-BETA AGGREGATION INHIBITORS. 10th Indian Peptide symposium 2025.02.26 Pune, India

  6. Tamamura H. Prevention of the Spread of Virus Infection in Global Societies: Peptidomimetic Antiviral Agents from HIV to SARS-CoV-2. 10th Indian Peptide Symposium 2025.02.26 Pune, India

  7. Tsuji K, Huang X, Miyamoto M, Yokoo H, Kobayakawa T, Demizu Y, Tamamura H. Utilization of HIV-1 Viral Protein R-derived Peptides as Novel E3 Ligase Ligands for Development of BRD4 Degraders. Chemical Biology Symposium 2025 2025.02.25 Bengaluru, India

  8. Yamamoto K, Kobayakawa T, Tsuji K, Tamamura H. CHLOROALKENE-TYPE DIPEPTIDE ISOSTERES APPLICATED FOR AMYLOID-BETA AGGREGATION INHIBITORS. Chemical Biology Symposium 2025 2025.02.25 Bengaluru, India

  9. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. DEVELOPMENT OF NOVEL SARS-COV-2 PAPAIN-LIKE PROTEASE INHIBITORS AND THEIR POTENTIAL APPLICATION TO ANTI-MPOX AGENTS. Chemical Biology Symposium 2025 2025.02.25 Bengaluru, India

  10. Tamamura H. Antibody-Drug-Conjugates (ADCs): Anti-HIV Agents . Chemical Biology Symposium 2025 2025.02.25 Bengaluru, India

  11. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. Development of novel inhibitors against a SARS-CoV-2 papain-like protease and their application to Mpox I7L protease inhibitors. 2nd EFMC International Symposium on Chemical Biology 2025.01.30 Basel, Switzerland

  12. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. Structure activity relationship studies of novel SARS-CoV-2 papain-like protease inhibitors. 25th World Congress on Medicinal Chemistry and Drug Design 2025.01.27 Bangkok, Thailand

  13. Tamamura H. Peptides and peptidomimetics for drug discovery. The 11th Joint Symposium between Chulalongkorn University and lBB/Science Tokyo on Biomedical Materials and Engineering, Chulalongkorn University 2025.01.25 Bangkok, Thailand

  14. Tsuji K, Huang X, Kobayakawa T, Burke TR Jr., Tamamura H. Development of high-affinity polo-like kinase 1 polo-box domain binding peptides by bivalent approaches. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  15. Yamamoto K, Kobayakawa T, Tsuji K, Tamamura H. Development of chloroalkene-type dipeptide isosteres for amyloid-beta aggregation inhibitors. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  16. Shinohara K, Kobayakawa T, Takamatsu Y, Tsuji K, Mitsuya H, Tamamura H. Structure-activity relationship studies of novel SARS-CoV-2 papain-like protease inhibitors and their application as anti-Mpox agents. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  17. Huang X, Tsuji K, KobayakawaT, Tamamura H. Investigation on degrader peptides targeting the polo-box domain for degradation of polo-like kinase 1. The 61st Japanese Peptide Symposium 2024.10.29 Nagoya

  18. Tamamura H. New horizon of drug discovery for anti-HIV drugs. The 82nd FIP World Congress of Pharmacy and Pharmaceutical Sciences, HIV treatment: the future of preventative care and management 2024.09.01 Cape Town, South Africa

  19. Tamamura H. Development of anti-HIV agents targeting HIV-Gag proteins using in silico screening . The 37th European Peptide Symposium (EPS) & 14th International Peptide Symposium (IPS) Satellite Workshops, Applications of computational AI/ML in peptide research with a roadmap to peptide drug and material development 2024.08.30 Florence, Italy

  20. Kobayakawa T, Azuma C, Yamamoto K , Tsuji K, Tamamura H. Convergent synthesis of peptidomimetic based on a chloroalkene dipeptide isostere and its application to inhibition against amyloid β aggregation. 14th International Peptide Symposium 2024.08.26 Florence, Italy

< 前のページ - 次のページ >

このページの先頭へ▲